Lilly’s $400 Billion Surge Reshapes Big Pharma, Rally
Eli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
Learn which cash rewards credit cards have no fees, allowing you to earn rewards without the financial burden. Make informed choices.
27,645 articlesEli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
Deciding how to own the S&P 500 can feel overwhelming. This guide breaks down the pros and cons of RSP versus VOO, sh...
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Bittensor TAO jumps after the Covenant-72B AI model goes live on Subnet 3, signaling a shift from governance token to...
Bitcoin climbed past key levels as soft U.S. payroll data cooled rate-hike expectations. Yet traders remain hedged, w...
Six sectors are signaling strong hiring for today’s graduates. A new market analysis highlights healthcare, software,...
Benutech launches SellScore and RefiScore to help real estate agents and mortgage lenders target high-potential homeo...
A family estate in a hot real estate market yields a six-figure tax surprise when an inherited home’s stepped-up basi...
Starbucks shows a credible turnaround with rising traffic and profits, while Chipotle contends with growth fatigue an...
SOXQ has surged 181.74% in the past year as AI chip demand powers gains across NVIDIA, Broadcom, and AMD, while the E...
Amazon Web Services released a landmark study on AI agent drift, arguing that the link between models and tools needs...
Eli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...